Quetiapine Tablet, Film Coated, Extended Release
Product Images NDC 60760-866

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 60760-866). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

866-30 (Quetiapine 60760 866 30)

Label for Quetiapine Extended Release Tablets, USP 200 mg, film-coated extended release oral tablets. The package quantity is 30 tablets. The label states it is packaged by St. Mary's Medical Park Pharmacy and manufactured by ScieGen Pharmaceuticals, Inc. Additional label text includes directions to use as directed and storage instructions to keep at controlled room temperature (15°-30°C). Barcodes, NDC 60760-866-30, and placeholder lot and expiration information are visible.*

FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (Quetiapine Fig01)

A Kaplan-Meier curve chart showing the proportion of patients with relapse (%) over time in months. The chart compares two groups: PLA and QTP XR, with the QTP XR group showing a lower proportion of relapse over the observed period of 7 months.*

FDA Label Image

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (Quetiapine Fig02)

A survival curve graph showing the proportion of patients with relapse (%) over time in weeks. The graph includes two plotted lines representing different treatment groups labeled as 'CTP + LIVAL' and 'PLA + LINVAL.' The x-axis indicates time in weeks up to 100, and the y-axis shows the proportion of patients with relapse ranging from 0 to 100%.*

FDA Label Image

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (Quetiapine Fig03)

A line graph showing the proportion of patients with relapse over time (weeks) comparing two groups: QTP + LIVIAL and PLA + LIVIAL. The y-axis represents the proportion of patients with relapse (%) and the x-axis represents time in weeks, from 0 to 100 weeks. The QTP + LIVIAL line shows a higher relapse proportion compared to the PLA + LIVIAL line over the study period.*

FDA Label Image

Structural Formula (Quetiapine Str)

Chemical structure of quetiapine, the active ingredient in Quetiapine Extended Release 200 mg oral tablets by ST. MARY'S MEDICAL PARK PHARMACY. The structure shows molecular groups consistent with quetiapine's chemical formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.